Table 3 The baseline characteristics of patients after PSM
From: The efficacy of surgery in advanced hepatocellular carcinoma: a cohort study
Characteristics | All patients, no. (%), 608 (100) | ||
|---|---|---|---|
Surgery, 165 (27.1) | Non-surgery, 443 (72.9) | P value | |
Gender | 0.977 | ||
Male | 135 (81.8) | 362 (81.7) | |
Female | 30 (18.2) | 81 (18.3) | |
Age at diagnosis | 0.765 | ||
30–44 | 7 (4.2) | 12 (2.7) | |
45–59 | 69 (41.8) | 179 (40.4) | |
60–74 | 71 (43.1) | 201 (45.4) | |
75–84 | 18 (10.9) | 51 (11.5) | |
Ethnicity | 0.511 | ||
White | 116 (70.3) | 324 (73.1) | |
Black | 23 (13.9) | 65 (14.7) | |
Others | 26 (15.8) | 54 (12.2) | |
Marital status | 0.284 | ||
Married | 100 (60.6) | 257 (58) | |
Single | 57 (34.5) | 174 (39.3) | |
Others | 8 (4.9) | 12 (2.7) | |
AJCC T stage | 0.635 | ||
T1 | 55 (33.4) | 145 (32.7) | |
T2 | 51 (30.9) | 121 (27.3) | |
T3 | 56 (33.9) | 159 (35.9) | |
T4 | 2 (1.2) | 14 (3.2) | |
TX | 1 (0.6) | 4 (0.9) | |
Year of diagnosis | 0.228 | ||
2004–2006 | 46 (27.9) | 107 (24.2) | |
2007–2009 | 49 (29.7) | 116 (26.2) | |
2010–2012 | 28 (17) | 109 (24.6) | |
2013–2015 | 42 (25.4) | 111 (25) | |
Tumor size | 0.532 | ||
≤ 3 cm | 37 (22.4) | 84 (19) | |
3–5 cm | 38 (23) | 117 (26.4) | |
> 5 cm | 90 (54.6) | 242 (54.6) | |
Tumor number | 0.208 | ||
1 | 141 (85.5) | 402 (90.7) | |
2 | 18 (10.9) | 34 (7.7) | |
3 | 5 (3) | 5 (1.1) | |
> 3 | 1 (0.6) | 2 (0.5) | |
Radiotherapy | 0.796 | ||
Yes | 11 (6.7) | 27 (6.1) | |
No | 154 (93.3) | 416 (93.9) | |
Chemotherapy | 0.950 | ||
Yes | 77 (46.7) | 208 (47) | |
No | 88 (53.3) | 235 (53) | |
Liver resection | 68 | – | |
Wedge or segmental resection | 27 | – | |
Lobectomy | 24 | – | |
Extended lobectomy | 14 | – | |
Hepatectomy | 3 | – | |
Non-liver resection | 97 | – | |
Local tumor destruction | 30 | – | |
Cryoablation | 2 | – | |
Percutaneous ethanol injection | 5 | – | |
Radiofrequency ablation | 53 | – | |
Others | 7 | – | |